Related Experiment Videos
Optimized retroviral transduction protocol for human progenitor cells utilizing fibronectin fragments
T Trarbach1, S Greifenberg, W Bardenheuer
1Department of Internal Medicine, West German Cancer Center, University of Essen, Germany.
Cytotherapy
|June 5, 2002
Summary
Optimized retroviral gene transfer protocols enhance transduction of clonogenic progenitors (CFU). This method increases CFU numbers and achieves high efficiency, even with moderate retroviral vector titers.
Area of Science:
- Hematopoietic stem cell research
- Gene therapy
- Retroviral vector technology
Background:
- Fibronectin (FN) fragment-mediated retroviral transduction is effective for hematopoietic stem cell gene transfer.
- Current protocols focus on stem cells, but clonogenic progenitors (CFU) may suffice for some applications.
Purpose of the Study:
- To optimize retroviral transduction protocols for clonogenic progenitors (CFU).
- To enhance gene transfer efficiency into CFU using fibronectin fragments.
Main Methods:
- Evaluated growth factors, transduction timing, CD34-selection, and heparin effects.
- Utilized a neomycin-phosphotransferase (neo(R))-expressing retroviral vector.
- Optimized protocols for CFU transduction.
Main Results:
- Multiple growth factors (G-CSF, GM-CSF) significantly enhanced CFU transduction.
- Optimal conditions included 24h prestimulation, 24-48h transduction with CH-296 FN-fragment, IL-3, IL-11, SCF, EPO, and GM-CSF.
- Achieved 90.7% transduction of bone marrow-derived CFU with moderate retroviral titers.
- CFU numbers increased 2.6-fold during the procedure.
- Heparin significantly inhibited transduction.
Conclusions:
- Presents an optimized protocol for efficient retroviral gene transfer into human clonogenic progenitor cells.
- Achieves high transduction efficiency even with moderate titer retroviral vectors.
- Provides a valuable method for gene therapy applications targeting progenitor cells.